I’m still extremely bullish on the big numbers. The prospects of a blockbuster buyout (anything in excess of $50 per share in my opinion) are tied to comprehensive data. That data needs to demonstrate wide application, improvement in combination - and a worldwide addressable market that proves the dosage demands and value per patient.
I truly think (and always have) that bisantrene will prove to be the next Keytruda.
DT and the BOD are working towards as much valuable and broad data as possible - as quickly as possible.
Gun to my head, I think we should achieve US$13-21bn or more - or about 2-4x the conservative Triangle Report, if we have the data to back it up. This would still be a bargain for BP even at the top end of that price range.
General Comments / Chat, page-9992
-
-
- There are more pages in this discussion • 1,372 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.70 |
Change
0.050(3.03%) |
Mkt cap ! $289.6M |
Open | High | Low | Value | Volume |
$1.66 | $1.70 | $1.63 | $181.9K | 109.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11946 | $1.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.75 | 27579 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11946 | 1.700 |
1 | 6605 | 1.635 |
1 | 10752 | 1.615 |
2 | 20016 | 1.610 |
2 | 21000 | 1.600 |
Price($) | Vol. | No. |
---|---|---|
1.750 | 27579 | 4 |
1.755 | 990 | 1 |
1.760 | 500 | 1 |
1.800 | 824 | 2 |
1.820 | 4000 | 3 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online